- $43.49m
- -$12.31m
- $15.30m
Annual cashflow statement for DermTech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 March 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.944 | -35.2 | -78.3 | -117 | -101 |
| Depreciation | |||||
| Non-Cash Items | -2.92 | 4.96 | 16.4 | 22.3 | 22.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.53 | 1.12 | -1.2 | -2.56 | 0.011 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.444 | -28.7 | -62.1 | -95.3 | -77 |
| Capital Expenditures | — | -1.83 | -2.72 | -3.31 | -0.902 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 137 | -39.5 | -9.79 | -1.01 | 30.8 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 137 | -41.3 | -12.5 | -4.32 | 29.9 |
| Financing Cash Flow Items | 0.025 | -1.44 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -137 | 78.9 | 230 | 0.917 | 6.08 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.419 | 8.87 | 156 | -98.7 | -41 |